BONDI SANDS BROAD SPECTRUM HYDRA UV PROTECT SPF 70 SUNSCREEN- avobenzone, homosalate, octisalate, octocrylene spray 
Baxter Laboratories Pty. Ltd.

----------

Bondi Sands Broad Spectrum Hydra UV Protect SPF 70 Sunscreen Spray

Active Ingredients

Avobenzone 3%, Homosalate 15%, Octisalate 5%, Octocrylene 10%

Purpose: Sunscreen

Uses

Warnings

For external use only

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

When using this product

keep out of eyes. Rinse with water to remove.

Directions

Inactive Ingredients: Water, Beeswax, C12-15 Alkyl Benzoate, Silica, PEG-15 Cocamine, Caprylyl Glycol, PEG-40 Stearate, Acrylates/Steareth-20 Methacrylate Copolymer, Caprylhydroxamic Acid, Glycerin, Carbomer, Sodium Hydroxide, Phenoxyethanol, Sodium Carrageenan, Aloe Barbadensis Leaf Juice, Tocopheryl Acetate, Sodium Chloride.

Questions?

888-266-0772 or visit bondisands.com

Product Packaging

bondi sands

The Australian tan

BROAD SPECTRUM

HYDRA

UV PROTECT

SPF 70

SUNSCREEN SPRAY

VERY WATER RESISTANT 80 MINUTES

PLANT BASED HYDRATION

REEF FRIENDLY

Australian Made

5.07 FL. OZ. (150mL)

hydra spray

BONDI SANDS BROAD SPECTRUM HYDRA UV PROTECT SPF 70 SUNSCREEN 
avobenzone, homosalate, octisalate, octocrylene spray
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:70157-017
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
AVOBENZONE (UNII: G63QQF2NOX) (AVOBENZONE - UNII:G63QQF2NOX) AVOBENZONE30 mg  in 1 mL
OCTOCRYLENE (UNII: 5A68WGF6WM) (OCTOCRYLENE - UNII:5A68WGF6WM) OCTOCRYLENE100 mg  in 1 mL
HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S) HOMOSALATE150 mg  in 1 mL
OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W) OCTISALATE50 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
CAPRYLHYDROXAMIC ACID (UNII: UPY805K99W)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
ALKYL (C12-15) BENZOATE (UNII: A9EJ3J61HQ)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE (UNII: 0A5MM307FC)  
WATER (UNII: 059QF0KO0R)  
ALOE VERA LEAF (UNII: ZY81Z83H0X)  
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
PEG-15 COCAMINE (UNII: 8L6LB12TSJ)  
CARRAGEENAN (UNII: 5C69YCD2YJ)  
YELLOW WAX (UNII: 2ZA36H0S2V)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
GLYCERIN (UNII: PDC6A3C0OX)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PEG-40 STEARATE (UNII: ECU18C66Q7)  
CAPRYLYL GLYCOL (UNII: 00YIU5438U)  
ETHYL ACRYLATE/METHACRYLIC ACID/STEARETH-20 METHACRYLATE COPOLYMER (UNII: EPA1872R1N)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:70157-017-01150 mL in 1 BOTTLE, SPRAY; Type 0: Not a Combination Product08/05/2021
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM02008/05/2021
Labeler - Baxter Laboratories Pty. Ltd. (740537709)

Revised: 1/2024
Document Id: 0fcd2f87-40c1-6f5d-e063-6394a90a34fc
Set id: 0fcd3aad-a828-7f12-e063-6394a90a2d54
Version: 1
Effective Time: 20240124
 
Baxter Laboratories Pty. Ltd.